↓ Skip to main content

Adherence to Statin Therapy and Attainment of LDL Cholesterol Targets in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)

Overview of attention for article published in Frontiers in Pharmacology, July 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Adherence to Statin Therapy and Attainment of LDL Cholesterol Targets in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)
Published in
Frontiers in Pharmacology, July 2022
DOI 10.3389/fphar.2022.888110
Pubmed ID
Authors

Jelle M. Beernink, Milou M. Oosterwijk, Job F. M. van Boven, Hiddo J. L. Heerspink, Stephan J. L. Bakker, Gerjan Navis, Roos M. Nijboer, Christina M. Gant, Heleen Haverkate, Willemien J. Kruik-Kollöffel, Gozewijn D. Laverman

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 1 4%
Lecturer 1 4%
Student > Doctoral Student 1 4%
Unknown 23 88%
Readers by discipline Count As %
Medicine and Dentistry 2 8%
Computer Science 1 4%
Unknown 23 88%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 July 2022.
All research outputs
#20,298,249
of 22,835,198 outputs
Outputs from Frontiers in Pharmacology
#10,071
of 16,070 outputs
Outputs of similar age
#346,000
of 433,816 outputs
Outputs of similar age from Frontiers in Pharmacology
#739
of 1,273 outputs
Altmetric has tracked 22,835,198 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,070 research outputs from this source. They receive a mean Attention Score of 4.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,816 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,273 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.